Influx HealthtechNSE:INFLUX -0.65%32 Market Cap is ₹6,690 Mil as of Jul. 13, 2026. GuruFocus rates NSE:INFLUX with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Influx Healthtech ranks worse than 65.23% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Influx Healthtech's share price for the quarter that ended in Mar. 2026 was ₹202. Influx Healthtech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 23 Mil. Therefore, Influx Healthtech's market cap for the quarter that ended in Mar. 2026 was ₹4,669 Mil.
Influx Healthtech's quarterly market cap
increased
from Mar. 2025 (₹0 Mil) to Sep. 2025 (₹3,945 Mil) and
increased
from Sep. 2025 (₹3,945 Mil) to Mar. 2026 (₹4,669 Mil).
Influx Healthtech's annual market cap
stayed the same
from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil) but then
increased
from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹4,437 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Influx Healthtech's Enterprise Value for Today is ₹6,325 Mil.
Influx Healthtech (NSE:INFLUX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Influx Healthtech Market Cap Related Terms
Influx Healthtech Market Cap Historical Data
* Premium members only.
The historical data trend for Influx Healthtech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Influx Healthtech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Influx Healthtech Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Influx Healthtech's Market Cap distribution charts can be found below:
* The bar in red indicates where Influx Healthtech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Influx Healthtech's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Influx Healthtech (NSE:INFLUX) has a Market Cap of ₹6,690 Mil as of Jul. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Influx Healthtech and its competitors. According to the industry distribution chart, Influx Healthtech ranks #668 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 65.2%.
Is Influx Healthtech's Market Cap too high?
Influx Healthtech's current Market Cap is ₹6,690 Mil. Based on the distribution chart, Influx Healthtech ranks #668 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Influx Healthtech has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Influx Healthtech ranks #668 out of 1024 companies for Market Cap. This places Influx Healthtech in the lower half of its industry. The industry median Market Cap is 212.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 212.63, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Influx Healthtech and its competitors. For the Drug Manufacturers industry, the median Market Cap is 212.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Influx Healthtech's current Market Cap is ₹6,690 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current Market Cap of ₹6,690 Mil. The current Market Cap is ₹6,690 Mil. Influx Healthtech's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current Market Cap is ₹6,690 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
32GF Score
Get the complete analysis for NSE:INFLUX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFLUX has been successfully added to your 